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umans, like many other mammals, are awake
through the daytime hours and sleep during the night.In
some people, this normal sleep-wake rhythm, so taken
for granted by most of us, can become chronically
impaired,leading to a group of disorders called circadian
rhythm sleep disorders (CRSDs). CRSDs are charac-
terized by a misalignment between the timing of the
individual’s sleep-wake rhythm and the 24-h social 
and physical environment. In patients with CRSDs,
sleep episodes occur at inappropriate times,often caus-
ing waking periods to occur at undesired times.
Consequently, the patient complains of insomnia or
excessive daytime sleepiness and impairment in various
areas of functioning.
The second edition of the International Classification
of Sleep Disorders (ICSD-2)
1 divides disorders of
sleep-wake schedule into three major categories:
CRSDs of primary origin, behaviorally induced
CRSDs, and CRSDs due to a substance. Behaviorally
induced CRSDs can emerge as a consequence of the
individual’s voluntary choice to create a temporal mis-
match between his or her sleep-wake cycle and envi-
ronmental conditions,as happens in shift work and jet
lag. This review will focus on primary CRSDs and
behavioral and psychiatric consequences of these dis-
orders.Alterations of the sleep-wake schedule follow-
ing treatment with psychoactive medications will also
be described in some detail.
Four types of primary CRSD are listed in the ICSD-2:
• Delayed sleep phase type,also known as delayed sleep
phase syndrome (DSPS), which is characterized by
habitual sleep-wake times that are delayed usually
more than 2 h relative to conventional or socially
acceptable times (Figure 1A).When forced to follow
an environmentally imposed schedule, these patients
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Circadian rhythm sleep disorders (CRSDs) arise when an
individual’s sleep-wake rhythm mismatches the environ-
mental 24-h schedule. Physiological data and genetic stud-
ies in patients with CRSDs suggest that these disorders
result from abnormal functioning of the circadian timing
system. Diagnosis involves recognition of the characteris-
tics of CRSDs, which can be achieved by clinical interview
and actigraphic monitoring of rest-activity patterns.
Bright-light therapy and melatonin administration have
proved to be the most effective treatment modalities of
CRSDs. In psychiatric practice, CRSDs can be encountered
on various occasions. Some evidence indicates that a
deviant sleep-wake schedule might be a predisposing fac-
tor to personality disorders. CRSDs can emerge as an iatro-
genic effect of certain psychoactive drugs, such as haloperi-
dol and fluvoxamine. It is not uncommon that the daytime
functional difficulties that accompany CRSDs are misinter-
preted as symptoms of psychopathology. Recognition and
awareness of these disorders should prevent years of erro-
neous diagnosis and treatment in these patients.    
© 2005, LLS SAS Dialogues Clin Neurosci. 2005;7:357-365.will complain of difficulties falling asleep and waking
up in the morning,and feel sleepy during the day.
•Advanced sleep phase type, also known as advanced
sleep phase syndrome (ASPS), which is characterized
by habitual sleep onset and wake-up times that are
several hours earlier than desired or socially accepted
(Figure 1B).This pattern results in symptoms of com-
pelling evening sleepiness,early sleep onset,and awak-
ening that is earlier than desired.
• Free-running type,also known as nonentrained type or
non–24-h sleep-wake syndrome,can be described by a
sleep-wake cycle that is usually longer than the 24-h
period.Sleep and wake episodes are delayed each day
to later hours,thus alternating between synchrony and
complete asynchrony with the environmental schedule
(Figure 1C).
• Irregular sleep-wake type, also known as irregular or
disorganized sleep-wake pattern, is characterized by
lack of clearly defined circadian sleep-wake rhythm.
Sleep and wake episodes are temporally disorganized
and variable throughout the 24-h period (Figure 1D).
These patients are likely to manifest inability to initi-
ate and maintain sleep at night,frequent daytime nap-
ping,and excessive daytime sleepiness.
1
In a study of clinical characteristics of patients with
CRSDs in Israel,
2 the vast majority of patients received
the diagnosis of DSPS (83.5%), 12.3% had non–24-h
sleep-wake syndrome, while only a handful of patients
suffered from an irregular sleep-wake pattern (1.9%) or
ASPS (1.3%).A similar distribution of frequencies was
reported in a sleep clinic in Japan.
3 Limited data are
available regarding the prevalence of CRSDs in the gen-
eral population. It appears that DSPS is more common
among adolescents living in Western countries (7.3%)
4
than among adults, where the estimated prevalence
ranges from 0.13% in Japan
5 to 0.17% in Norway.
6ASPS
was estimated to occur in 1% of middle-aged and older
adults.
7 The prevalence of non–24-h sleep-wake syn-
drome and irregular sleep-wake pattern in the general
population is unknown.The majority of patients with
CRSDs (89.6%) report that the disorder typically begins
in early childhood or adolescence.
2There are no known
gender differences.
Pathophysiology
It is currently believed that CRSDs result from an abnor-
mality of circadian timing system,which regulates the diur-
nal rhythms of an organism.The core component of this
system is the suprachiasmatic nucleus (SCN) of the hypo-
thalamus.This internal biological clock has self-generated,
endogenous near-circadian rhythmicity,which it conveys
through direct and indirect pathways to a widely spread
network of subcortical and cortical sites.Thus,many phys-
iological functions,such as hormonal secretion and body
temperature,as well as cognitive performance and emo-
tional state, fluctuate according to the time of day.
8-11
Regulation of the circadian rhythm of sleep-wake cycle
involves secretion of the hormone melatonin by the pineal
gland, one of the central target sites of the SCN.
12 The
endogenous biological clock is synchronized or entrained
with the environment through time cues,such as light.
13
What abnormality in the complex mechanisms of the cir-
cadian timing system gives rise to CRSDs is still a matter
of debate.Among the four disorders of the sleep-wake
schedule,DSPS has been the subject of most scientific
research.In addition to sleep,circadian rhythms of mela-
tonin and core body temperature
14,15 were observed to be
delayed in this disorder. Further, the phase angle
between sleep timing, core body temperature rhythm,
and melatonin rhythm was noted to be altered in patients
with DSPS.
14-16Whereas exposure to bright light at night
acutely reduces melatonin concentration in subjects with
typical sleep-wake rhythm,this effect is even greater in
patients with DSPS.
17 Several hypotheses have been pro-
posed to explain how these characteristics produce
DSPS,none of which has yet been confirmed or refuted.
Some findings demonstrate that a genetic origin might be
present in CRSDs. In as many as 44% of patients with
CRSDs,there is evidence that other family members have
similar sleep-wake patterns as the patient.
2 In the pedigree
of one family with DSPS,the trait was found to segregate
with either an autosomal dominant mode of heritance with
incomplete penetrance or a multifactorial mode of inher-
itance.
18 Structural polymorphisms on one of the haplo-
types of the human period3 gene (hper3) were implicated
as contributors to increased susceptibility to DSPS.
19
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Selected abbreviations and acronyms
ADD attention deficit disorder
ADHD attention deficit/hyperactivity disorder
ASPS advanced sleep phase syndrome
CRSD circadian rhythm sleep disorder
DSPS delayed sleep phase syndrome
PRC phase-response curve
SCN suprachiasmatic nucleusSeveral pedigrees of familial ASPS were reported,in which
the ASPS trait segregated as an autosomal-dominant mode
of inheritance.
20,21Although a mutation of human period2
(hper2) gene was identified in a large family with ASPS,
22
other findings indicate genetic heterogeneity in this disor-
der.
23The exact mechanisms by which mutations in clock
genes produce the physiological and behavioral pheno-
types of CRSDs remain to be elaborated.
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Figure 1. Actigrams of patients with disordered sleep-wake schedules. Sleep episodes are represented by white areas, wake episodes by black areas. The
24-h period is double-plotted in a raster format. A. Delayed sleep phase syndrome. B. Advanced sleep phase syndrome. C. Non–24-h sleep-wake
syndrome. D. Irregular sleep-wake pattern.
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CDDiagnosis
Diagnosis of CRSDs involves two complementary pro-
cedures. A clinical interview should evaluate the
patient’s sleep-wake habits and presence of sleep com-
plaints (such as insomnia and daytime sleepiness).
Several additional characteristics might be sought for
more accurate diagnosis of CRSDs, such as (i) impair-
ment in different areas of functioning:these patients are
frequently unable to keep a steady job, follow a school
timetable,and maintain a normal social life;(ii) rigidity
of sleep-wake patterns: it is extremely difficult for
patients with CRSDs to adjust to new sleep-wake rou-
tines;(iii) hereditary trends:as shown above,other fam-
ily members, such as parents, siblings, offspring, aunts,
and uncles, are likely to have similar sleep-wake sched-
ules to the patient; (iv) history of head injury or brain
tumors: previous findings indicate that CRSDs can
emerge as a secondary disorder associated with these
conditions
24-31;(v) drug intake:as will be described below,
CRSDs can also appear as a side effect of psychoactive
medications.If DSPS is suspected,it might also be help-
ful to question the patient about his or her preferences
in regard to mealtimes and hours of alertness. Patients
with a delayed sleep-wake schedule usually report lack
of appetite in the morning and choose evening hours as
the best time for activities involving alertness and con-
centration.
The second procedure is the confirmation of informa-
tion collected in the clinical interview by 7 to 14 days of
sleep logs and/or actigraphic monitoring.The actigraph
is a watch-sized device worn on the wrist sampling hand
motion.A computerized algorithm can provide highly
reliable data on sleep and wake periods of the patient.
32,33
The documentation of sleep-wake cycles requires mon-
itoring for at least several days; therefore, actigraphy is
the most appropriate objective tool for diagnosing
CRSDs,and in most cases polysomnography is not nec-
essary.Importantly,actigraphic monitoring must be con-
ducted in free conditions, since sleep-wake schedule
obtained under forced conditions can mask the pattern
of the schedule,thus misleading the diagnosis.
Treatment
At present, bright-light therapy and melatonin treat-
ment,or a combination of the two,have proved to be the
most effective treatment modalities for patients with
CRSDs.These techniques aim to reset the sleep-wake
cycle of the patients to match the external 24-h sched-
ule.
Bright light is one of the most powerful time cues for the
internal circadian timing system.Light exposure at spe-
cific times of the 24-h period can result in a phase-shift
in the endogenous circadian rhythms of a variety of
functions, such as melatonin secretion, body tempera-
ture, and sleep propensity.
34-36 These time-dependent
effects of light were described by phase-response curves
(PRCs).
13,37 In general, morning bright-light exposure
induces a phase advance, whereas evening bright light
exposure induces phase delay.
Using the entraining properties of light to synchronize
sleep-wake schedule of patients with CRSDs has
become an increasingly popular therapy.Artificial bright
light applied by light devices at the intensities of 2000 to
4000 lux has been successfully used to realign the circa-
dian phase of patients with DSPS and ASPS, and some
evidence supports its effectiveness in treatment of non-
entrained type sleep disorders, jet lag, shift work, and
dementia.
38 The American Academy of Sleep Medicine
has provided the recommended intensities and time lim-
its for phototherapy in the treatment of these disorders.
38
Endogenous melatonin secreted by the pineal gland is
another potent regulator of the sleep-wake cycle. It is
thought that the nighttime increase in melatonin concen-
tration reduces body temperature, which promotes the
onset of sleep.
39 Previous findings have demonstrated that
pharmacological preparations of melatonin mimic the
effects of endogenous melatonin,which are time-depen-
dent:phase advance is produced by melatonin adminis-
tered in the evening,whereas melatonin administration in
the morning induces phase delays.
40 Thus, the PRC to
melatonin is about 12 h out of phase with the PRC to
light.
41Administration of melatonin might be a preferable
therapeutic strategy for many patients, who find pho-
totherapy too demanding,leading to decreased compli-
ance.The beneficial effects of 0.5 to 5 mg/day melatonin
have been demonstrated in several types of CRSDs.
42-46
Importantly,treatment with melatonin not only synchro-
nizes the sleep-wake cycle of patients with CRSDs,but
also significantly and clinically meaningfully improves
several dimensions of their daytime functioning.
47
Although some recent well-designed studies indicate that
even relatively large doses of melatonin (10 mg/day for a
month) have no toxicological effects,
48 its long-term
effects remain to be fully researched and resolved.
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fail to help, a rehabilitative approach is recommended.
The patients should be guided to accept that their con-
dition is permanent, and should be encouraged to con-
sider changes in lifestyle that will be congruent with
their sleep-wake cycle.
49
CRSDs in psychiatry
As was described in several recent reviews,
50-52 chrono-
biological disturbances may play a crucial role in the
pathogenesis of major psychiatric disorders, such as
unipolar and bipolar depression, seasonal affective dis-
order, schizophrenia, and neurodegenerative illnesses.
In the present review,we will specifically focus on cases
where psychiatric practice might encounter disorders of
the sleep-wake schedule.
CRSDs and personality disorders
In a large sample of 322 patients with CRSDs who
attended a sleep clinic,72 patients (22.4%) were diagnosed
with personality disorders based on clinical interview.
2To
confirm this preliminary finding a controlled study was
conducted,in which the incidence of personality disorders
was examined in a group of 50 patients with DSPS or free-
running pattern in comparison with 56 healthy controls.
53
Personality disorders in both groups were assessed using
the Millon Clinical Multiaxial Inventory
54 and Personality
Diagnostic Questionnaire-Revised.
55The major finding of
this study was that patients with CRSDs suffer more fre-
quently from personality disorders than do normal con-
trols.No specific pattern or profile of personality disorders
could be clearly detected over and above the existence of
general personality pathology.
53
In a complementary study, the sleep-wake habits of 63
adolescents hospitalized in psychiatric wards were exam-
ined.
56 None of the patients had any diagnosed medical
disorders,and all received psychoactive medications.The
patients suffered from a variety of psychiatric disorders,
including schizophrenia and other psychotic disorders;
mood disorders;personality disorders;disorders usually
first diagnosed in infancy,childhood,and adolescence;anx-
iety disorders; and substance-related disorders. Sixteen
percent of the adolescents were diagnosed as having
DSPS.As predicted, the probability of comorbid DSPS
among patients with personality disorders was significantly
higher than among patients with any other psychiatric dis-
order.Further,all of the patients with DSPS suffered from
disorders characterized by affective lability,namely bipo-
lar disorder,schizoaffective disorder classified as mainly
affective,and borderline personality disorder.
56
These findings have led the authors to suggest that there
may be an interrelationship between CRSDs and person-
ality disorders. It is noticeable that both disorders are
defined by the Diagnostic and Statistical Manual of Mental
Disorders,Fourth Edition (DSM-IV)
57 as primarily involv-
ing a mismatch between the expectations of the society in
which the individual lives and his or her own behavioral
pattern.The direction of causality is difficult to determine.
It might be that personality disorders are characterized by
a deviant sleep-wake pattern as one expression of the gen-
eral deviation from the expectations of society. On the
other hand,peculiarities of the biological clock might lead
to emotional,social,and functional difficulties that subse-
quently escalate into a personality disorder.According to
this latter hypothesis,a deviant sleep-wake schedule fre-
quently emerges early in life,possibly harming the mother
and the child’s mutual ability to adapt to each other.The
mother, required to adjust to a biological clock of her
infant that differs markedly from her own,becomes tired,
frustrated,and angry,causing the infant to respond accord-
ingly.The resulting emotional burden,carried by both par-
ties,might jeopardize the attachment processes,thus affect-
ing future prospects of personal and social relationships of
the child.At later stages of life,such a child has difficulties
following the school timetable of activities,fails to obtain
a sufficient amount of sleep at night,loses concentration
during the morning and early afternoon hours,and,even-
tually,falls behind other children in school.Frequently,the
abnormal sleep-wake cycle of individuals with CRSDs and
the accompanying dysfunction at school or work are mis-
attributed by parents,educators,psychologists,and other
health care professionals to psychological rather than bio-
logical factors,such as laziness and low motivation.This
attitude toward individuals with CRSDs,to which they are
subjected since the early childhood or adolescence,adds
psychological distress to the practical difficulties of coping
with life and contributes to the development of personal-
ity disorders.
2,53,56
CRSDs and psychoactive medication
Several cases of disrupted sleep-wake schedule as an iatro-
genic effect of psychoactive drugs have been documented
in the literature. Treatment with a typical neuroleptic,
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361haloperidol,in a patient with chronic schizophrenia was
associated with an irregular sleep-wake cycle.Switching
treatment to the atypical neuroleptic clozapine established
a more organized and stable sleep-wake pattern and
improved the clinical state of the patient.
58 To further
explore the relationship between type of drug and rest-
activity patterns, seven additional patients with schizo-
phrenia were studied.Four of these patients received typ-
ical neuroleptics (flupentixol or haloperidol) and showed
a variety of abnormalities in the daily rest-activity rhythm,
eg,delayed circadian phase syndrome,free-running sleep-
wake syndrome,and irregular sleep-wake pattern with a
circabidian component (approximately 48 h).On the other
hand, rest-activity cycles of those patients treated with
atypical neuroleptic clozapine (three patients) were highly
organized and synchronized with the environmental
schedule.
59
Similar effects were observed in a female patient with
early-onset Alzheimer’s disease: when treated with
haloperidol,her rest-activity patterns became completely
arrhythmic;this was accompanied by marked worsening
of the cognitive state.When haloperidol was replaced by
clozapine, rapid normalization of the sleep-wake cycle
occurred and cognitive functioning improved.
60Additional
evidence arises from a case study describing a male patient
with Gilles de la Tourette syndrome,who was successfully
treated with haloperidol.
61 Prior to haloperidol treatment,
the patient reported having a normal sleep-wake sched-
ule.Two years after commencing the treatment,he exhib-
ited an irregular sleep-wake cycle with a dominant 48-h
circabidian component.When therapy with haloperidol
was changed to atypical neuroleptic risperidone,the tim-
ing and duration of sleep episodes became more orga-
nized, although his sleep-wake schedule still remained
somewhat disturbed.Addition of melatonin as a secondary
therapy fully recovered the patient’s sleep-wake circadian
rhythm. This was accompanied by improvement in his
quality of life,social interactions,and employment status.
61
These findings support the proposition that whereas atyp-
ical neuroleptics like clozapine and risperidone enhance
the congruity of the individual’s sleep-wake cycle with the
environment,typical neuroleptics like haloperidol and flu-
pentixol might alter the circadian sleep-wake rhythm.
Since this effect was evident in several medical disorders,eg,
schizophrenia,Alzheimer’s disease,and Tourette syndrome,
it was argued that CRSDs are side effects of typical neu-
roleptics,rather than an illness-related phenomenon.
58-61The
exact mechanisms through which typical and atypical neu-
roleptics exert their differential effects on sleep-wake cycle
remain to be elucidated.
Clinical evidence indicates that apart from neuroleptics
other psychoactive drugs,such as specific selective sero-
tonin inhibitors (SSRIs), can trigger the emergence of
CRSDs as a side effect. Hermesh et al
62 described 10
patients with obsessive-compulsive disorder who devel-
oped DSPS during fluvoxamine treatment. It was pos-
tulated that delayed sleep-wake schedule in this case
series was iatrogenic to fluvoxamine based on the fol-
lowing observations: (i) all patients received no other
medications except fluvoxamine prior to the onset of
DSPS; (ii) in all patients, DSPS first occurred following
fluvoxamine initiation;(iii) when fluvoxamine was with-
drawn or the dose considerably reduced,the sleep-wake
cycle returned to normal; and (iv) with reexposure to
fluvoxamine, DSPS recurred. Interestingly, emergence
of DSPS was quite specific to fluvoxamine; treatment
with two other SSRIs (clomipramine and fluoxetine) has
not been associated with any adverse effects on sleep-
wake cycle of these patients.The authors hypothesized
that the alteration of sleep-wake schedule or the lack of
it by different SSRI agents might depend on the differ-
ential effects of these drugs on serum melatonin levels.
62
To summarize,the above cases indicate that certain psy-
choactive medications might have adverse effects on the
circadian rhythm of the sleep-wake cycle.To date, we
have clinical evidence of such effects for haloperidol,flu-
pentixol,and fluvoxamine.Whether there are additional
psychotropics associated with disruptions of the sleep-
wake schedule,whether the response is dose- and time-
dependent, and what the characteristics are of the par-
ticular patients who might develop CRSDs while on
these drugs,remain questions for future research.At this
stage, however, sleep-related complaints of patients
treated with psychoactive drugs,especially haloperidol,
flupentixol, and fluvoxamine, should not always be
regarded as drug-induced insomnia or daytime somno-
lence. As the findings demonstrate, in some cases
CRSDs might be taken into consideration as a possible
side effect.When iatrogenic CRSD is suspected,chang-
ing therapy and/or adding melatonin might be initiated.
CRSDs and psychiatric misdiagnosis
Difficulties in daytime functioning are one of the promi-
nent characteristics of CRSDs.Individuals with CRSDs
frequently fail to adjust to the activity hours accepted in
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incompatibility of their internal biological rhythms with
the environmental timetable. Consider, for example, a
patient with DSPS who is expected to arrive at his work-
place by 8 or 9 AM. In order to fulfill this requirement,
this individual is forced to wake up at what might be the
middle of his internal night. It is not surprising, there-
fore,that he will be frequently late and/or absent,a pat-
tern that will most likely subject him to disciplinary
actions up to dismissal.If,however,he manages to meet
the attendance standards,his performance will be liable
to the detrimental effects of sleep loss and time of day.
In childhood and adolescence, when CRSDs usually
emerge, the impairment of daytime functioning can be
even more remarkable than in adults.Unlike adults,who
can at times choose a lifestyle that corresponds to their
sleep-wake cycle, the activity hours of persons of
younger age are constrained by a strictly predetermined
school timetable.The inability to adjust to this timetable
may be associated with deteriorated school perfor-
mance. In a recent study, we found that the vast major-
ity of young patients with DSPS complained of frequent
late arrivals and absences at school,underachievement,
and behavioral/social difficulties.Importantly,treatment
with melatonin significantly reduced the number of chil-
dren and adolescents complaining of malfunctioning at
school.
63
In some cases, the daytime functional difficulties might
be severe enough to be mistakenly interpreted as symp-
toms of psychiatric disorders.A case of a 14-year-old boy
provides a dramatic illustration of such a scenario.
64
During the 4 years prior to his referral to our sleep
clinic,the patient suffered from major functioning diffi-
culties, including conflicts with teachers, parents, and
peers.At the age of 12,the patient dropped out of school
and was sent to an inpatient child-psychiatry center.
Three months of psychiatric evaluation yielded diag-
noses of atypical depressive disorder with possible
schizotypal personality disorder. Due to excessive day-
time sleepiness, he was referred to our sleep clinic for
assessment of a potential sleep disorder. A thorough
sleep study revealed that the patient had a 26-h sleep-
wake schedule and dissociation between oral tempera-
ture and salivary melatonin rhythms.He was diagnosed
with non–24-h sleep-wake pattern.
Treatment with oral melatonin normalized the sleep-
wake schedule within a month,and follow-up actigraphy
after 6 months of melatonin treatment revealed a full
entrainment to a 24-h day. The patient returned to
school after a year of absence and succeeded in filling
the gaps of missing studies.At the end of the first semes-
ter, his school report showed excellent results. His par-
ents also reported an improvement in the patient’s rela-
tionship with his family and peers. In a repeated
psychiatric evaluation by licensed psychiatrists,none of
the previously described severe diagnoses were present,
and the boy showed no evidence of psychopathology,as
was previously thought.
64 Over the years of treating
patients with CRSDs, we evidenced a considerable
amount of similar case histories, some of which were
previously documented.
49
In this context, the association between CRSDs and
attention deficit disorder (ADD) and attention
deficit/hyperactivity disorder (ADHD) should also be
mentioned. A relatively high prevalence (19.3%) of
these disorders was reported in a large sample of
patients with CRSDs attending a sleep clinic.
2 In a recent
retrospective study of 45 children and adolescents with
DSPS (aged 6 to 18) who were treated with melatonin,
almost half of the sample had a comorbid diagnosis of
ADD or ADHD pretreatment.
63 The treatment
advanced the sleep-wake cycle of these patients and
improved their daytime functioning in educational set-
tings.Interestingly,many of them were able to reduce or
discontinue psychotherapy and/or stimulant medication
during melatonin therapy.This finding indicates that,at
least in some cases,CRSD-related dysfunctional behav-
iors might be erroneously interpreted as symptoms of
ADD/ADHD.
Conclusion
CRSDs are sleep pathologies associated with multilevel
disturbances in daily functioning.These disorders can be
relatively easily diagnosed and treated with several avail-
able treatment modalities.Yet many cases of CRSDs are
underrecognized and misdiagnosed as psychiatric disor-
ders or psychophysiological insomnia.Consequently,these
patients receive inappropriate treatment, such as hyp-
notics,which can enhance the psychological distress and
add to the adjustment difficulties that accompany CRSDs.
It is of great importance to raise the awareness of these
disorders on the part of pediatricians,physicians,neurolo-
gists,psychiatrists,and psychologists. ❏
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Consecuencias conductuales y psiquiátricas
de los trastornos del ciclo sueño-vigilia
Los trastornos del ritmo circadiano de sueño (CRSD)
surgen cuando el ritmo sueño-vigilia de un sujeto
se desajusta con el ciclo ambiental de 24 horas. Los
datos fisiológicos y los estudios genéticos en pacien-
tes con CRSD sugieren que estos trastornos derivan
de un funcionamiento anormal del sistema de
ritmo circadiano. El diagnóstico involucra el reco-
nocimiento de las características del CRSD, el cual
se puede obtener a través de la entrevista clínica y
del registro actigráfico de los patrones de reposo-
actividad. La terapia de luz brillante y la adminis-
tración de melatonina han demostrado ser las
modalidades terapéuticas más efectivas para los
CRSD. En la práctica psiquiátrica los CRSD se pueden
encontrar en varias ocasiones. Existe alguna evi-
dencia que indica que una desviación del ciclo
sueño-vigilia puede ser un factor de predisposición
para los trastornos de la personalidad. Los CRSD
pueden aparecer como un efecto iatrogénico de
ciertos psicofármacos como haloperidol y fluvoxa-
mina. No es infrecuente que las dificultades fun-
cionales que acompañan a los CRSD durante el día
sean mal interpretadas como síntomas de psicopa-
tología. El conocimiento y la identificación de los
CRSD debería prevenir años de diagnósticos y tra-
tamientos erróneos en estos pacientes.       
Conséquences psychiatriques et comporte-
mentales des troubles du cycle veille-sommeil
Les troubles du rythme circadien du sommeil (TRCS)
se produisent quand le rythme veille-sommeil d’un
individu perturbe le cycle environnemental de 24
heures. Les données physiologiques et les études
génétiques chez les patients ayant des TRCS suggè-
rent que ces troubles résultent d’un fonctionnement
anormal du système de la chronologie circadienne.
Le diagnostic comporte la reconnaissance des carac-
téristiques des TRCS, qui peuvent se faire par un
interrogatoire clinique et un monitoring actigra-
phique des schémas repos-activité. Il a été prouvé
que le traitement par la lumière brillante et l’admi-
nistration de mélatonine sont les traitements les plus
efficaces des TRCS. En pratique psychiatrique, les
TRCS peuvent se rencontrer dans diverses occasions.
Nous avons la preuve qu’un schéma veille-sommeil
perturbé peut être un facteur prédisposant à des
troubles de la personnalité. Les TRCS peuvent surve-
nir en tant qu’effet iatrogène de certains médica-
ments psychoactifs, tels que l’halopéridol et la flu-
voxamine. Il n’est pas rare que les difficultés
fonctionnelles de la journée qui accompagnent les
TRCS soient faussement interprétées comme des
symptômes d’une psychologie pathologique. La
reconnaissance et la prise de conscience des TRCS
devraient éviter des années de traitement et de dia-
gnostic erronés chez ces patients.
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